(NASDAQ:XLO), WALTHAM, Mass., July 02, 2025 (GLOBE NEWSWIRE) — Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that, effective July 1, 2025, the company granted non-qualified stock options to purchase 10,700 shares of its common stock to two new employees under […]
(NASDAQ:ITRM), DUBLIN and CHICAGO, July 02, 2025 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) (“Iterum” or the “Company”), a company committed to delivering next generation oral and IV antibiotics to address infections caused by multi-drug resistant pathogens, today announced that it has granted a non-statutory share option to purchase an aggregate of 200,000 ordinary
(NYSE:TOL), FORT WASHINGTON, Pa., July 02, 2025 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE: TOL) (TollBrothers.com), the nation's leading builder of luxury homes, through its Toll Brothers Apartment Living(R) rental division, and Gables Residential have announced a new joint venture to develop Gables Angeline, a four-story, 243-unit luxury multifamily rental community in Littleton, Colorado. The
(NasdaqGM:BIGC), AUSTIN, Texas, July 02, 2025 (GLOBE NEWSWIRE) — BigCommerce Holdings, Inc. (“BigCommerce”) (Nasdaq: BIGC), an open SaaS, composable ecommerce platform for fast-growing and established B2C and B2B brands and retailers, today announced it will report its financial results for the second quarter ended June 30, 2025, before market open on Thursday, July 31, 2025.
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire July 02, 2025 SAN FRANCISCO, July 02, 2025 (GLOBE NEWSWIRE) — Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, today announced that the Company
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire July 02, 2025 WALTHAM, Mass., July 02, 2025 (GLOBE NEWSWIRE) — Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that, effective July 1, 2025, the company granted non-qualified stock options
Iterum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire July 02, 2025 DUBLIN and CHICAGO, July 02, 2025 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) (“Iterum” or the “Company”), a company committed to delivering next generation oral and IV antibiotics to address infections caused by multi-drug resistant pathogens, today announced that it
Mercer further improves Sustainalytics ESG Risk Rating, ranking in the top 15% globally GlobeNewswire July 02, 2025 NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) — Mercer International Inc. (“Mercer” or the “Company”) (Nasdaq: MERC), a global forest products company with operations in Germany, the U.S., and Canada, announces that it has received an updated ESG
Toll Brothers Apartment Living(R) and Gables Residential Announce Joint Venture to Develop 243-Unit Luxury Multifamily Community in Littleton, Colorado JV secures $57 million construction loan from JPMorgan Chase GlobeNewswire July 02, 2025 FORT WASHINGTON, Pa., July 02, 2025 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE: TOL) (TollBrothers.com), the nation's leading builder of luxury homes, through
BigCommerce to Announce Second Quarter 2025 Financial Results on July 31, 2025 Conference Call Scheduled for 8:00 a.m. ET on July 31, 2025 GlobeNewswire July 02, 2025 AUSTIN, Texas, July 02, 2025 (GLOBE NEWSWIRE) — BigCommerce Holdings, Inc. (“BigCommerce”) (Nasdaq: BIGC), an open SaaS, composable ecommerce platform for fast-growing and established B2C and B2B brands